|
1
|
Patton JG, Porro EB, Galceran J, Tempst P
and Nadal-Ginard B: Cloning and characterization of PSF, a novel
pre-mRNA splicing factor. Genes Dev. 7:393–406. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dong B, Horowitz DS, Kobayashi R and
Krainer AR: Purification and cDNA cloning of HeLa cell p54nrb, a
nuclear protein with two RNA recognition motifs and extensive
homology to human splicing factor PSF and Drosophila NONA/BJ6.
Nucleic Acids Res. 21:4085–4092. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prasanth KV, Prasanth SG, Xuan Z, Hearn S,
Freier SM, Bennett CF, Zhang MQ and Spector DL: Regulating gene
expression through RNA nuclear retention. Cell. 123:249–263. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dye BT and Patton JG: An RNA recognition
motif (RRM) is required for the localization of PTB-associated
splicing factor (PSF) to subnuclear speckles. Exp Cell Res.
263:131–144. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shav-Tal Y, Cohen M, Lapter S, Dye B,
Patton JG, Vandekerckhove J and Zipori D: Nuclear relocalization of
the pre-mRNA splicing factor PSF during apoptosis involves
hyperphosphorylation, masking of antigenic epitopes, and changes in
protein interactions. Mol Biol Cell. 12:2328–2340. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shav-Tal Y, Blechman J, Darzacq X,
Montagna C, Dye BT, Patton JG, Singer RH and Zipori D: Dynamic
sorting of nuclear components into distinct nucleolar caps during
transcriptional inhibition. Mol Biol Cell. 16:2395–2413. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Z and Carmichael GG: The fate of
dsRNA in the nucleus: A p54(nrb)-containing complex mediates the
nuclear retention of promiscuously A-to-I edited RNAs. Cell.
106:465–475. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sharathchandra A, Lal R, Khan D and Das S:
Annexin A2 and PSF proteins interact with p53 IRES and regulate
translation of p53 mRNA. RNA Biol. 9:1429–1439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Emili A, Shales M, McCracken S, Xie W,
Tucker PW, Kobayashi R, Blencowe BJ and Ingles CJ: Splicing and
transcription-associated proteins PSF and p54nrb/nonO bind to the
RNA polymerase II CTD. RNA. 8:1102–1111. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu X, Yoo Y, Okuhama NN, Tucker PW, Liu G
and Guan JL: Regulation of RNA-polymerase-II-dependent
transcription by N-WASP and its nuclear-binding partners. Nat Cell
Biol. 8:756–763. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferrai C, Naum-Onganía G, Longobardi E,
Palazzolo M, Disanza A, Diaz VM, Crippa MP, Scita G and Blasi F:
Induction of HoxB transcription by retinoic acid requires actin
polymerization. Mol Biol Cell. 20:3543–3551. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mathur M, Tucker PW and Samuels HH: PSF is
a novel corepressor that mediates its effect through Sin3A and the
DNA binding domain of nuclear hormone receptors. Mol Cell Biol.
21:2298–2311. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dong X, Sweet J, Challis JR, Brown T and
Lye SJ: Transcriptional activity of androgen receptor is modulated
by two RNA splicing factors, PSF and p54nrb. Mol Cell Biol.
27:4863–4875. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duong HA, Robles MS, Knutti D and Weitz
CJ: A molecular mechanism for circadian clock negative feedback.
Science. 332:1436–1439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong L, Zhang X, Fu X, Zhang X, Gao X, Zhu
M, Wang X, Yang Z, Jensen ON, Saarikettu J, et al: PTB-associated
splicing factor (PSF) functions as a repressor of STAT6-mediated Ig
epsilon gene transcription by recruitment of HDAC1. J Biol Chem.
286:3451–3459. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Imamura K, Imamachi N, Akizuki G, Kumakura
M, Kawaguchi A, Nagata K, Kato A, Kawaguchi Y, Sato H, Yoneda M, et
al: Long Noncoding RNA NEAT1-Dependent SFPQ relocation from
promoter region to paraspeckle mediates IL8 Expression upon immune
stimuli. Mol Cell. 54:10552014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang G, Cui Y, Zhang G, Garen A and Song
X: Regulation of proto-oncogene transcription, cell proliferation,
and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA.
Proc Natl Acad Sci USA. 106:16794–16798. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heyd F and Lynch KW: PSF controls
expression of histone variants and cellular viability in
thymocytes. Biochem Biophys Res Commun. 414:743–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ha K, Takeda Y and Dynan WS: Sequences in
PSF/SFPQ mediate radioresistance and recruitment of
PSF/SFPQ-containing complexes to DNA damage sites in human cells.
DNA Repair (Amst). 10:252–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morozumi Y, Takizawa Y, Takaku M and
Kurumizaka H: Human PSF binds to RAD51 and modulates its
homologous-pairing and strand-exchange activities. Nucleic Acids
Res. 37:4296–4307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rajesh C, Baker DK, Pierce AJ and Pittman
DL: The splicing-factor related protein SFPQ/PSF interacts with
RAD51D and is necessary for homology-directed repair and sister
chromatid cohesion. Nucleic Acids Res. 39:132–145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Salton M, Lerenthal Y, Wang SY, Chen DJ
and Shiloh Y: Involvement of Matrin 3 and SFPQ/NONO in the DNA
damage response. Cell Cycle. 9:1568–1576. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Melton AA, Jackson J, Wang J and Lynch KW:
Combinatorial control of signal-induced exon repression by hnRNP L
and PSF. Mol Cell Biol. 27:6972–6984. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
King HA, Cobbold LC, Pichon X, Pöyry T,
Wilson LA, Booden H, Jukes-Jones R, Cain K, Lilley KS, Bushell M
and Willis AE: Remodelling of a polypyrimidine tract-binding
protein complex during apoptosis activates cellular IRESs. Cell
Death Differ. 21:161–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsukahara T, Matsuda Y and Haniu H: PSF
knockdown enhances apoptosis via downregulation of LC3B in human
colon cancer cells. Biomed Res Int. 2013:2049732013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsukahara T, Haniu H and Matsuda Y:
PTB-associated splicing factor (PSF) is a PPARγ-binding protein and
growth regulator of colon cancer cells. PLoS One. 8:e587492013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cho S, Moon H, Loh TJ, Oh HK, Williams DR,
Liao DJ, Zhou J, Green MR, Zheng X and Shen H: PSF contacts exon 7
of SMN2 pre-mRNA to promote exon 7 inclusion. Biochim Biophys Acta.
1839:517–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ke YD, Dramiga J, Schütz U, Kril JJ,
Ittner LM, Schröder H and Götz J: Tau-mediated nuclear depletion
and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's
disease. PLoS One. 7:e356782012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kok VJT, Tang JY, Eng GWL, Tan SY, Chin
JTF, Quek CH, Lai WX, Lim TK, Lin Q, Chua JJE and Cheong JK: SFPQ
promotes RAS-mutant cancer cell growth by modulating 5′-UTR
mediated translational control of CK1α. NAR Cancer. 4:zcac0272022.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang L, Yang J, Jacobson B, Gilbertsen A,
Smith K, Higgins L, Guerrero C, Xia H, Henke CA and Lin J: SFPQ
promotes lung cancer malignancy via regulation of CD44 v6
expression. Front Oncol. 12:8622502022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang L, Gilbertsen A, Jacobson B, Pham J,
Fujioka N, Henke CA and Kratzke RA: SFPQ and Its Isoform as
Potential Biomarker for Non-Small-Cell Lung Cancer. Int J Mol Sci.
24:125002023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin Y, Zhong W, Lin Q, Ye Y, Li S, Chen H,
Liu H, Xu L, Zhuang W, Chen S, et al: SFPQ promotes the
proliferation, migration and invasion of hepatocellular carcinoma
cells and is associated with poor prognosis. Am J Cancer Res.
13:2269–2284. 2023.PubMed/NCBI
|
|
33
|
Xiao M, Wang F, Chen N, Zhang H, Cao J, Yu
Y, Zhao B, Ji J, Xu P, Li L, et al: Smad4 sequestered in SFPQ
condensates prevents TGF-β tumor-suppressive signaling. Dev Cell.
59:48–63.e8. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yarosh CA, Iacona JR, Lutz CS and Lynch
KW: PSF: Nuclear busy-body or nuclear facilitator? Wiley
Interdiscip Rev RNA. 6:351–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fox AH, Bond CS and Lamond AI: P54nrb
forms a heterodimer with PSP1 that localizes to paraspeckles in an
RNA-dependent manner. Mol Biol Cell. 16:5304–5315. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kuwahara S, Ikei A, Taguchi Y, Tabuchi Y,
Fujimoto N, Obinata M, Uesugi S and Kurihara Y: PSPC1, NONO, and
SFPQ are expressed in mouse Sertoli cells and may function as
coregulators of androgen receptor-mediated transcription. Biol
Reprod. 75:352–359. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thandapani P, O'Connor TR, Bailey TL and
Richard S: Defining the RGG/RG motif. Mol Cell. 50:613–623. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kiledjian M and Dreyfuss G: Primary
structure and binding activity of the hnRNP U protein: Binding RNA
through RGG box. EMBO J. 11:2655–2664. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Maris C, Dominguez C and Allain FH: The
RNA recognition motif, a plastic RNA-binding platform to regulate
post-transcriptional gene expression. FEBS J. 272:2118–2131. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cléry A, Sinha R, Anczuków O, Corrionero
A, Moursy A, Daubner GM, Valcárcel J, Krainer AR and Allain FH:
Isolated pseudo-RNA-recognition motifs of SR proteins can regulate
splicing using a noncanonical mode of RNA recognition. Proc Natl
Acad Sci USA. 110:E2802–E2811. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Passon DM, Lee M, Rackham O, Stanley WA,
Sadowska A, Filipovska A, Fox AH and Bond CS: Structure of the
heterodimer of human NONO and paraspeckle protein component 1 and
analysis of its role in subnuclear body formation. Proc Natl Acad
Sci USA. 109:4846–4850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sasaki YT and Hirose T: How to build a
paraspeckle. Genome Biol. 10:2272009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jacobs FM, van Erp S, van der Linden AJ,
von Oerthel L, Burbach JP and Smidt MP: Pitx3 potentiates Nurr1 in
dopamine neuron terminal differentiation through release of
SMRT-mediated repression. Development. 136:531–540. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Saud K, Cánovas J, Lopez CI, Berndt FA,
López E, Maass JC, Barriga A and Kukuljan M: SFPQ associates to
LSD1 and regulates the migration of newborn pyramidal neurons in
the developing cerebral cortex. Int J Dev Neurosci. 57:1–11. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gao Z, Chen M, Tian X, Chen L, Chen L,
Zheng X, Wang H, Chen J, Zhao A, Yao Q, et al: A novel human lncRNA
SANT1 cis-regulates the expression of SLC47A2 by altering
SFPQ/E2F1/HDAC1 binding to the promoter region in renal cell
carcinoma. RNA Biol. 16:940–949. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dong J, Pervaiz W, Tayyab B, Li D, Kang L,
Zhang H, Gong H, Ma X, Li J, Agboyibor C, et al: A comprehensive
comparative study on LSD1 in different cancers and tumor specific
LSD1 inhibitors. Eur J Med Chem. 240:1145642022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lopez CI, Saud KE, Aguilar R, Berndt FA,
Cánovas J, Montecino M and Kukuljan M: The chromatin modifying
complex CoREST/LSD1 negatively regulates notch pathway during
cerebral cortex development. Dev Neurobiol. 76:1360–1373. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cai W, Xiao C, Fan T, Deng Z, Wang D, Liu
Y, Li C and He J: Targeting LSD1 in cancer: Molecular elucidation
and recent advances. Cancer Lett. 598:2170932024. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hirose T, Virnicchi G, Tanigawa A,
Naganuma T, Li R, Kimura H, Yokoi T, Nakagawa S, Bénard M, Fox AH
and Pierron G: NEAT1 long noncoding RNA regulates transcription via
protein sequestration within subnuclear bodies. Mol Biol Cell.
25:169–183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Urban RJ, Bodenburg Y, Kurosky A, Wood TG
and Gasic S: Polypyrimidine tract-binding protein-associated
splicing factor is a negative regulator of transcriptional activity
of the porcine p450scc insulin-like growth factor response element.
Mol Endocrinol. 14:774–782. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cheng Z, Lu C, Wang H, Wang N, Cui S, Yu
C, Wang C, Zuo Q, Wang S, Lv Y, et al: Long noncoding RNA
LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by
interacting with SFPQ to regulate TXNIP expression. Cancer Lett.
531:1–13. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ma H, Han P, Ye W, Chen H, Zheng X, Cheng
L, Zhang L, Yu L, Wu X, Xu Z, et al: The long Noncoding RNA NEAT1
exerts antihantaviral effects by acting as positive feedback for
RIG-I signaling. J Virol. 91:e02250–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dong F, Qin X, Wang B, Li Q, Hu J, Cheng
X, Guo D, Cheng F, Fang C, Tan Y, et al: ALKBH5 facilitates
hypoxia-induced paraspeckle assembly and IL8 secretion to generate
an immunosuppressive tumor microenvironment. Cancer Res.
81:5876–5888. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rosonina E, Ip JY, Calarco JA, Bakowski
MA, Emili A, McCracken S, Tucker P, Ingles CJ and Blencowe BJ: Role
for PSF in mediating transcriptional activator-dependent
stimulation of pre-mRNA processing in vivo. Mol Cell Biol.
25:6734–6746. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mora Gallardo C, Sánchez de Diego A,
Gutiérrez Hernández J, Talavera-Gutiérrez A, Fischer T, Martínez AC
and van Wely KHM: Dido3-dependent SFPQ recruitment maintains
efficiency in mammalian alternative splicing. Nucleic Acids Res.
47:5381–5394. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kim J, Lee Y, Jeon T, Ju S, Kim JS, Kim MS
and Kang C: Autophagy-dependent splicing control directs
translation toward inflammation during senescence. Dev Cell.
60:364–378.e7. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hu Z, Dong L, Li S, Li Z, Qiao Y, Li Y,
Ding J, Chen Z, Wu Y, Wang Z, et al: Splicing Regulator
p54(nrb)/Non-POU domain-containing octamer-binding protein enhances
carcinogenesis through oncogenic isoform switch of MYC
box-dependent interacting protein 1 in hepatocellular carcinoma.
Hepatology. 72:548–568. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Bernard A, Hibos C, Richard C, Viltard E,
Chevrier S, Lemoine S, Melin J, Humblin E, Mary R, Accogli T, et
al: The tumor microenvironment impairs Th1 IFNγ secretion through
alternative splicing modifications of Irf1 Pre-mRNA. Cancer Immunol
Res. 9:324–336. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xie R, Chen X, Cheng L, Huang M, Zhou Q,
Zhang J, Chen Y, Peng S, Chen Z, Dong W, et al: NONO inhibits
lymphatic metastasis of bladder cancer via alternative splicing of
SETMAR. Mol Ther. 29:291–307. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
An Y and Duan H: The role of m6A RNA
methylation in cancer metabolism. Mol Cancer. 21:142022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang T, Kong S, Tao M and Ju S: The
potential role of RNA N6-methyladenosine in Cancer progression. Mol
Cancer. 19:882020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Song H, Wang Y, Wang R, Zhang X, Liu Y,
Jia G and Chen PR: SFPQ Is an FTO-binding protein that facilitates
the demethylation substrate preference. Cell Chem Biol.
27:283–291.e6. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Thivierge C, Bellefeuille M, Diwan SS,
Dyakov BJA, Leventis R, Perron G, Najafabadi HS, Gravel SP, Gingras
AC and Duchaine TF: Paraspeckle-independent co-transcriptional
regulation of nuclear microRNA biogenesis by SFPQ. Cell Rep.
43:1146952024. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Bottini S, Hamouda-Tekaya N, Mategot R,
Zaragosi LE, Audebert S, Pisano S, Grandjean V, Mauduit C, Benahmed
M, Barbry P, et al: Post-transcriptional gene silencing mediated by
microRNAs is controlled by nucleoplasmic Sfpq. Nat Commun.
8:11892017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Fukuda Y, Pazyra-Murphy MF, Silagi ES,
Tasdemir-Yilmaz OE, Li Y, Rose L, Yeoh ZC, Vangos NE, Geffken EA,
Seo HS, et al: Binding and transport of SFPQ-RNA granules by
KIF5A/KLC1 motors promotes axon survival. J Cell Biol.
220:e2020050512021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Mitobe Y, Iino K, Takayama KI, Ikeda K,
Suzuki T, Aogi K, Kawabata H, Suzuki Y, Horie-Inoue K and Inoue S:
PSF promotes ER-positive breast cancer progression via
posttranscriptional regulation of ESR1 and SCFD2. Cancer Res.
80:2230–2242. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yang X and Wu H: RAS signaling in
carcinogenesis, cancer therapy and resistance mechanisms. J Hematol
Oncol. 17:1082024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhang F, Virshup DM and Cheong JK:
Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis.
Oncogene. 37:363–376. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhao M, Mishra L and Deng CX: The role of
TGF-β/SMAD4 signaling in cancer. Int J Biol Sci. 14:111–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhang H, Su X, Burley SK and Zheng XFS:
mTOR regulates aerobic glycolysis through NEAT1 and nuclear
paraspeckle-mediated mechanism in hepatocellular carcinoma.
Theranostics. 12:3518–3533. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Bi O, Anene CA, Nsengimana J, Shelton M,
Roberts W, Newton-Bishop J and Boyne JR: SFPQ promotes an oncogenic
transcriptomic state in melanoma. Oncogene. 40:5192–5203. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Wu CF, Tan GH, Ma CC and Li L: The
non-coding RNA llme23 drives the malignant property of human
melanoma cells. J Genet Genomics. 40:179–188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zheng LQ, Chi SM and Li CX: Rab23′s
genetic structure, function and related diseases: A review. Biosci
Rep. 37:BSR201604102017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Yasuhara T, Xing YH, Bauer NC, Lee L, Dong
R, Yadav T, Soberman RJ, Rivera MN and Zou L: Condensates induced
by transcription inhibition localize active chromatin to nucleoli.
Mol Cell. 82:2738–2753.e6. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Klotz-Noack K, Klinger B, Rivera M,
Bublitz N, Uhlitz F, Riemer P, Lüthen M, Sell T, Kasack K, Gastl B,
et al: SFPQ depletion is synthetically Lethal with BRAF(V600E) in
colorectal cancer cells. Cell Rep. 32:1081842020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Heinemann V, Douillard JY, Ducreux M and
Peeters M: Targeted therapy in metastatic colorectal cancer-an
example of personalised medicine in action. Cancer Treat Rev.
39:592–601. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Cancer Genome Atlas Network, .
Comprehensive molecular characterization of human colon and rectal
cancer. Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yaeger R and Corcoran RB: Targeting
alterations in the RAF-MEK pathway. Cancer Discov. 9:329–341. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Khamidullina AI, Abramenko YE, Bruter AV
and Tatarskiy VV: Key proteins of replication stress response and
cell cycle control as cancer therapy targets. Int J Mol Sci.
25:12632024. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Takayama KI: Splicing factors have an
essential role in prostate cancer progression and androgen receptor
signaling. Biomolecules. 9:1312019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Takayama KI, Suzuki T, Fujimura T, Yamada
Y, Takahashi S, Homma Y, Suzuki Y and Inoue S: Dysregulation of
spliceosome gene expression in advanced prostate cancer by
RNA-binding protein PSF. Proc Natl Acad Sci USA. 114:10461–10466.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Jayson GC, Kohn EC, Kitchener HC and
Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Pellarin I, Dall'Acqua A, Gambelli A,
Pellizzari I, D'Andrea S, Sonego M, Lorenzon I, Schiappacassi M,
Belletti B and Baldassarre G: Splicing factor proline- and
glutamine-rich (SFPQ) protein regulates platinum response in
ovarian cancer-modulating SRSF2 activity. Oncogene. 39:4390–4403.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Sun S, Gao T, Pang B, Su X, Guo C, Zhang R
and Pang Q: RNA binding protein NKAP protects glioblastoma cells
from ferroptosis by promoting SLC7A11 mRNA splicing in an
m(6)A-dependent manner. Cell Death Dis. 13:732022. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
de Silva HC, Lin MZ, Phillips L, Martin JL
and Baxter RC: IGFBP-3 interacts with NONO and SFPQ in
PARP-dependent DNA damage repair in triple-negative breast cancer.
Cell Mol Life Sci. 76:2015–2030. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Mishchenko TA, Olajide OJ, Gorshkova EN,
Vedunova MV and Krysko DV: Regulated cell death modalities:
Breaking resistance of temozolomide glioblastoma therapy. Trends
Cancer. 11:430–432. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Sun N, Chen Q, Chen H, Sun P, Liu Y, Song
D, Yu D, Wang P, Song Y, Qin J, et al: A novel nuclear RNA HSD52
scaffolding NONO/SFPQ complex modulates DNA damage repair to
facilitate temozolomide resistance. Neuro Oncol. 27:963–978. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wang Y and Chen LL: Organization and
function of paraspeckles. Essays Biochem. 64:875–882. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wang Z, Li K and Huang W: Long non-coding
RNA NEAT1-centric gene regulation. Cell Mol Life Sci. 77:3769–3779.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Fox AH, Lam YW, Leung AK, Lyon CE,
Andersen J, Mann M and Lamond AI: Paraspeckles: A novel nuclear
domain. Curr Biol. 12:13–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Naganuma T, Nakagawa S, Tanigawa A, Sasaki
YF, Goshima N and Hirose T: Alternative 3′-end processing of long
noncoding RNA initiates construction of nuclear paraspeckles. EMBO
J. 31:4020–4034. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Knott GJ, Bond CS and Fox AH: The DBHS
proteins SFPQ, NONO and PSPC1: A multipurpose molecular scaffold.
Nucleic Acids Res. 44:3989–4004. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
An H, Tan JT and Shelkovnikova TA: Stress
granules regulate stress-induced paraspeckle assembly. J Cell Biol.
218:4127–4140. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
McCluggage F and Fox AH: Paraspeckle
nuclear condensates: Global sensors of cell stress? Bioessays.
43:e20002452021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Pisani G and Baron B: NEAT1 and
paraspeckles in cancer development and chemoresistance. Noncoding
RNA. 6:432020.PubMed/NCBI
|
|
96
|
Zhu Y, Hu H, Yuan Z, Zhang Q, Xiong H, Hu
Z, Wu H, Huang R, Wang G and Tang Q: LncRNA NEAT1 remodels
chromatin to promote the 5-Fu resistance by maintaining colorectal
cancer stemness. Cell Death Dis. 11:9622020. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Reavie L, Buckley SM, Loizou E, Takeishi
S, Aranda-Orgilles B, Ndiaye-Lobry D, Abdel-Wahab O, Ibrahim S,
Nakayama KI and Aifantis I: Regulation of c-Myc ubiquitination
controls chronic myelogenous leukemia initiation and progression.
Cancer Cell. 23:362–375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Zeng C, Liu S, Lu S, Yu X, Lai J, Wu Y,
Chen S, Wang L, Yu Z, Luo G and Li Y: The c-Myc-regulated lncRNA
NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML
cells. Mol Cancer. 17:1302018. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Bhattacharya A, Wang K, Penailillo J, Chan
CN, Fushimi A, Yamashita N, Daimon T, Haratake N, Ozawa H,
Nakashoji A, et al: MUC1-C regulates NEAT1 lncRNA expression and
paraspeckle formation in cancer progression. Oncogene.
43:2199–2214. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Yang L, Fang C, Zhang R and Zhou S:
Prognostic value of oxidative stress-related genes in colorectal
cancer and its correlation with tumor immunity. BMC Genomics.
25:82024. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Torres S, García-Palmero I, Marín-Vicente
C, Bartolomé RA, Calviño E, Fernández-Aceñero MJ and Casal JI:
Proteomic characterization of transcription and splicing factors
associated with a metastatic phenotype in colorectal cancer. J
Proteome Res. 17:252–264. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhang D, Yang S, Li Y, Yao J, Ruan J,
Zheng Y, Deng Y, Li N, Wei B, Wu Y, et al: Prediction of overall
survival among female patients with breast cancer using a
prognostic signature based on 8 DNA repair-related genes. JAMA Netw
Open. 3:e20146222020. View Article : Google Scholar : PubMed/NCBI
|
